Takeda and GammaDelta Therapeutics announces collaboration
Takeda and GammaDelta Therapeutics collaborate to advance tissue-derived gamma delta (γδ) T Cells. The post Takeda and GammaDelta Therapeutics announces collaboration appeared first on PharmaAsia.
View ArticleSanpower Group completes acquisition of Dendreon from Valeant
Chinese company completes acquisition of U.S. firm providing FDA-approved cellular immunotherapy for prostate cancer. The post Sanpower Group completes acquisition of Dendreon from Valeant appeared...
View ArticleTabuk Pharmaceuticals signs exclusive in-licensing agreement with Dong A
Tabuk has entered into an in-licensing agreement with Dong to in-license Zydena "Udenafil Tabs" in KSA and the Gulf area. The post Tabuk Pharmaceuticals signs exclusive in-licensing agreement with Dong...
View ArticleINC Research and inVentiv Health announce successful completion of merger
Combination creates the only fully integrated biopharmaceutical solutions organization with combined net revenue of more than US$3 billion. The post INC Research and inVentiv Health announce successful...
View ArticleLifeArc, Metrion to support neuroscience molecule drug discovery programme
Both companies announced an extension of their existing partnership to support LifeArc’s neuroscience drug discovery programme. The post LifeArc, Metrion to support neuroscience molecule drug discovery...
View ArticleJohnson & Johnson partners with CSIR-IMTECH to develop new tuberculosis...
MOU aims to increase level and accelerate pace of innovation needed to make tuberculosis history. The post Johnson & Johnson partners with CSIR-IMTECH to develop new tuberculosis treatments...
View ArticleFullerton Health expands Australian medical platform through acquisition of HMC
HMC operates a network of medical centres across Australia. The post Fullerton Health expands Australian medical platform through acquisition of HMC appeared first on PharmaAsia.
View ArticleSamsung Bioepis, Takeda to co-develop multiple novel biologic therapies
Companies will jointly fund and co-develop multiple novel biologic therapies in unmet disease areas. The post Samsung Bioepis, Takeda to co-develop multiple novel biologic therapies appeared first on...
View ArticleLigand to receive US$2mn from WuXi Biologics for licensing antibody
Ligand is also entitled to future milestones and royalties from this antibody. The post Ligand to receive US$2mn from WuXi Biologics for licensing antibody appeared first on PharmaAsia.
View ArticlePAREXEL, Osaka International Cancer Institute form alliance to advance...
Alliance to drive greater efficiencies across clinical trials in oncology and haematology. The post PAREXEL, Osaka International Cancer Institute form alliance to advance clinical research appeared...
View ArticleAmbrosus, Trek Therapeutics to develop blockchain-powered method in...
Ambrosus will conduct pilot projects with Trek to monitor the quality, safety and integrity of all stages of the pharmaceutical manufacturing process. The post Ambrosus, Trek Therapeutics to develop...
View ArticleDaiichi Sankyo enters licencing agreement with Boston Pharmaceuticals for RET...
Daiichi Sankyo grants Boston Pharmaceuticals worldwide rights for the research, development, manufacturing and commercialisation of DS-5010. The post Daiichi Sankyo enters licencing agreement with...
View ArticleQED Clinical Services chooses Acceliant as a clinical data management platform
The collaboration will have Acceliant provide QED Clinical Services with the ability to completely transform the latter's clinical trials. The post QED Clinical Services chooses Acceliant as a clinical...
View ArticleGlaxoSmithKline Japan selects SciBite Semantic platform to enhance...
GSK Japan has selected SciBite's Semantic Platform to deliver on its commitment to improve the quality of human life. The post GlaxoSmithKline Japan selects SciBite Semantic platform to enhance...
View ArticleCongenica selected by Coimbra Paediatric Hospital for genetic disease...
The hospital has licensed Sapientia software platform to perform analysis of whole-exome sequencing data and produce disease diagnostic reports. The post Congenica selected by Coimbra Paediatric...
View ArticleMerck, Project Data Sphere to pioneer Global Oncology Big Data Alliance
Merck and Project Data Sphere big data platform to help accelerate innovative discovery, development and delivery of new approaches in cancer care. The post Merck, Project Data Sphere to pioneer Global...
View ArticleMD Anderson, Daiichi Sankyo collaborate to accelerate development of acute...
The collaboration will launch multiple phase 1 and 2 clinical trials conducted by MD Anderson with the aim of expediting delivery of new therapies. The post MD Anderson, Daiichi Sankyo collaborate to...
View ArticleEpiVax to use ‘Immune History’ to protect against bird flu
EpiVax, Inc. has announced a new NIH-funded collaboration to develop a protective avian influenza A (H7N9) vaccine. The post EpiVax to use ‘Immune History’ to protect against bird flu appeared first on...
View ArticleAplagon and Cadila Pharmaceuticals to develop APAC first-in-class...
A new Aplagon-Cadila Pharmaceuticals partnership is focused on APAC first-in-class antithrombotics, with clinical trials expected to commence in 2019. The post Aplagon and Cadila Pharmaceuticals to...
View ArticleAcceliant, Turacoz Healthcare Solutions enter alliance to expand clinical...
Acceliant and Turacoz Healthcare Solutions have partnered up in a bid to further improve product offerings and address major industry challenges. The post Acceliant, Turacoz Healthcare Solutions enter...
View Article
